Allergan Lumigan FDA Approved Solution
The Allergan Lumigan has been approved by the Food and Drug Administration as it has been proven to reduce the increasing pressure in the eye which is commonly known as intra-ocular pressure (IOP) among people who have ocular hypertension or open-angle glaucoma. Alergan Lumigan (0.01%) is a kind of optimized prescription with a lowered absorption on bimatoprost. Both Allergan Lumigan (0.01%) and (0.03%) are commended for use in patients with elevated IOP. They served as an initial treatment which targets to reduce the pressure in the eye. These two formulation of provide a convenient dosage since they are only prescribed to be taken once a day.
Many might be questioning the relevance of Lumigan (Allergan Lumigan) for people. Now, many know that the occurrence of glaucoma makes a prominent cause for avertable blindness primarily in people from US and at the same time affects roughly 3 million individuals all over the nation and an estimate of 65 million individuals all over the world. The increased IOP corresponds to a chief risk aspect for loss in vision related with the open-angle glaucoma. The condition also makes the sole risk factor which can recently be treated. Per concept, the higher is the intra-ocular pressure, the higher is the possibility for the optic nerve to get ruined, which can potentially result to loss of vision and blindness.
Allergan Lumigan Positive Effects
Several situations have already illustrated the positive effects of Allergan Lumigan however certain scenarios have also brought up the downfalls of the product. Studies further show that the use of Allergan Lumigan can generate certain side effects. Reports have stated that the product can cause transformation on the pigmented tissues. Perhaps the most common changes that have been reported were the heightened pigmentation in the eyelashes, iris, and eyelid. This pigmentation is anticipated to grow higher provided the bimatoprost is directed. Changes in pigmentation are triggered due to the stimulation of the content of melanin right in the so called melanocytes instead of growing the volume of melanocytes.
Once the use for bimatoprost is discontinued, pigmentation that develops in the iris will be likely lasting, while the pigmentation on periorbital tissue as well as the eyelash changes was reported to be repealed in some people. Patients who used the drug must then be educated about the chance of heightened pigmentation. Color changes in the iris may remain unnoticeable for some months or years. Characteristically, brown pigmentation occurring surrounding the pupil shall extend concentrically in the direction of iris periphery and the whole iris or portion of iris turns more brownish.
Allergan Lumigan Uses
Allergan Lumigan
The use of Allergan Lumigan must be done with caution. People must learn the necessary safety measures. They should be extra cautious if they have dynamic intra-ocular inflammation like uveitis since inflammation can be aggravated. To make sure that you are safe to undergo with the treatment, it would be best to consult your doctor. Although it is understandable for anyone to use products that will aid their condition, they shouldn’t forget ensuring their safety first.
